Annual report pursuant to Section 13 and 15(d)

Contingencies and commitments - Noile-Immune Collaboration Agreement (Details)

v3.24.0.1
Contingencies and commitments - Noile-Immune Collaboration Agreement (Details) - License agreement - Noile Immune Biotech Inc. - USD ($)
Aug. 26, 2019
Dec. 31, 2023
Contingencies and commitments    
Upfront license fees $ 2,500,000  
Maximum    
Contingencies and commitments    
Potential milestone payments   $ 312,000,000